PBAE-PEG/Lipid Nanoparticle Delivery of RNA for the Creation of Genetically Engineered Lung Cancer Mouse Models

Résumé fourni par la source

We have recently developed polymer/lipid nanoparticles PBAE-PEG/4A3-SC8/DOPE/Cholesterol/DOTAP (hereafter, PBAE-PEG/LNP) that can deliver mRNA into lung cells. Here, using PBAE-PEG/LNP, we delivered Cre mRNA and/or sgRNAs into Kras LSL-G12D/+ and/or Cas9 mice to develop genetically engineered lung cancer mouse models. PBAE-PEG/LNP delivery of Cre mRNA into Kras LSL-G12D/+;Cas9 mice by intratracheal (IT) injection produced autochthonous lung tumors while intravenous injection resulted in lung tumors as well as bronchus-associated lymphoid tissue (BALT). PBAE-PEG/LNP delivery of Cre mRNA along with sgRNA targeting the lung lineage transcription factor Nkx2-1 (sgNkx2-1) into Kras LSL-G12D/+;Cas9 mice by IT injection produced autochthonous invasive mucinous adenocarcinoma of the lung (IMA) that lacks NKX2-1 while expressing the gastrointestinal transcription factor HNF4A. PBAE-PEG/LNP delivery of sgRNAs targeting Eml4 (sgEml4) and Alk (sgAlk) into Cas9 mice by IT injection produced autochthonous lung tumors carrying the driver oncogene Eml4-Alk . This approach using PBAE-PEG/LNP to deliver RNA will allow for agile development of lung cancer mouse models.

Ce résumé expose les affirmations des auteurs. BNTIC ne l’interprète pas comme une validation indépendante des résultats.